医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

GLUT1 expression, lymphocyte distribution and CD3<sup>+</sup> T-cell metabolic subsets as predictive markers of response to immunotherapy in advanced melanoma.

广告
第一作者: Elizabeth C,Paver
第一单位: Melanoma Institute Australia, The University of Sydney, Sydney, Australia.;Department of Anatomical Pathology, ACT Pathology, Canberra Health Services, Canberra, Australia.;School of Medicine and Psychology, Australian National University, Canberra, Australia.
作者单位: Melanoma Institute Australia, The University of Sydney, Sydney, Australia.;Department of Anatomical Pathology, ACT Pathology, Canberra Health Services, Canberra, Australia.;School of Medicine and Psychology, Australian National University, Canberra, Australia. [1] Melanoma Institute Australia, The University of Sydney, Sydney, Australia. tuba.gide@sydney.edu.au.;Charles Perkins Centre, The University of Sydney, Sydney, Australia. tuba.gide@sydney.edu.au.;Faculty of Medicine and Health, The University of Sydney, Sydney, Australia. tuba.gide@sydney.edu.au. [2] Melanoma Institute Australia, The University of Sydney, Sydney, Australia.;Charles Perkins Centre, The University of Sydney, Sydney, Australia. [3] Melanoma Institute Australia, The University of Sydney, Sydney, Australia.;Charles Perkins Centre, The University of Sydney, Sydney, Australia.;Faculty of Medicine and Health, The University of Sydney, Sydney, Australia. [4] Melanoma Institute Australia, The University of Sydney, Sydney, Australia.;Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia.;NSW Health Pathology, Sydney, Australia. [5] Melanoma Institute Australia, The University of Sydney, Sydney, Australia.;Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.;Royal North Shore Hospital, Sydney, Australia.;Mater Hospital, North Sydney, Australia. [6] Melanoma Institute Australia, The University of Sydney, Sydney, Australia.;Westmead and Blacktown Hospitals, Sydney, Australia. [7] Melanoma Institute Australia, The University of Sydney, Sydney, Australia.;Charles Perkins Centre, The University of Sydney, Sydney, Australia.;Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.;Champalimaud Foundation, Lisbon, Portugal. [8] School of Biomedical Sciences, UNSW Sydney, Kensington, Australia. [9] Melanoma Institute Australia, The University of Sydney, Sydney, Australia.;Charles Perkins Centre, The University of Sydney, Sydney, Australia.;Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.;Royal North Shore Hospital, Sydney, Australia.;Mater Hospital, North Sydney, Australia. [10] Melanoma Institute Australia, The University of Sydney, Sydney, Australia.;Charles Perkins Centre, The University of Sydney, Sydney, Australia.;Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.;Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia.;NSW Health Pathology, Sydney, Australia. [11]
DOI 10.1186/s13046-025-03637-8
PMID 41559679
发布时间 2026-02-15
提交
  • 浏览0
Journal of experimental & clinical cancer research : CR

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷